G2GBIO Inc. (KOSDAQ:456160)
South Korea · Delayed Price · Currency is KRW 41,300
-1,050 (-2.48%)
At close: Aug 11, 2026
G2GBIO Market Cap
G2GBIO has a market cap or net worth of 683.32 billion as of August 12, 2026.
Market Cap
683.32B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
41,300.00
ChartMarket Cap Chart
Since August 14, 2025, G2GBIO's market cap has increased from 503.30B to 683.32B, an increase of 35.77%. That is a compound annual growth rate of 36.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 683.32B | -37.89% |
| Dec 30, 2025 | 1.10T | 118.59% |
| Aug 14, 2025 | 503.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 313.98B |
| HEM Pharma | 299.96B |
| NOVAREX | 288.14B |
| Cosmax Nbt | 214.18B |
| DAE HWA Pharmaceutical | 192.68B |
| CellBion | 185.58B |
| Vivozon Pharmaceutical | 177.49B |
| GC WellBeing | 173.82B |